Business Context and Reporting Period
Nexalin Technology, Inc. (NXL), a Delaware corporation and emerging growth company, filed this Form 8-K on July 2, 2024, reporting events occurring on July 1, 2024. The filing details the consummation of a public offering of common stock.
Key Financial Metrics
- Gross Proceeds: Approximately $5,250,000 from the sale of 3,000,000 shares of Class A common stock.
- Placement Agent Fee: 8% of gross proceeds.
- Expense Reimbursement: $110,000 paid to the Placement Agent (Maxim Group LLC).
- Net Proceeds: The filing does not provide a clear calculated value for net proceeds after deducting the fee and expenses.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics.
Material Changes
The primary material change is the increase in equity capital following the closing of the Offering. The company issued 3,000,000 new shares, resulting in gross proceeds of $5,250,000. This transaction was executed pursuant to a Securities Purchase Agreement and a Placement Agency Agreement entered into on June 27, 2024.
Guidance, Outlook, and Risks
- Use of Proceeds: Net proceeds are intended for general corporate purposes, including working capital, operating expenses, and capital expenditures.
- Management Commentary: The filing confirms the Offering was conducted on a "best efforts" basis and references a press release issued on June 27, 2024, regarding the pricing.
- Risks and Contingencies: The filing notes customary representations, warranties, indemnification obligations, and termination provisions within the agreements but does not detail specific new risks or contingencies beyond standard transaction terms.
Investor Verification Checklist
- Verify the exact net proceeds by calculating the 8% fee and $110,000 expense reimbursement against the $5,250,000 gross proceeds.
- Review the full text of the Placement Agency Agreement (Exhibit 1.2) and Securities Purchase Agreement (Exhibit 10.16) for specific covenants or restrictions.
- Confirm the impact of the 3,000,000 new shares on existing shareholder dilution.
- Check the press release (Exhibit 99.1) for additional details on the pricing mechanism and investor composition.